Abstract
The Bcl-2 family proteins include pro- and antiapoptotic factors acting as critical arbiters of apoptotic cell death decisions in most circumstances. Evasion of apoptosis is one of the hallmarks of cancer, relevant to tumorigenesis as well as resistance to cytotoxic drugs, and deregulation of Bcl-2 proteins was observed in many cancers. Since Bax-mediated induction of apoptosis is a crucial mechanism in cancerous cells, we aimed at conducting in silico analysis on Bax in order to predict the possible interactions for anticancer agents. The present report depicts the binding mode of aloe-emodin and its structurally modified derivatives onto Bax. The structural information about the binding site of Bax for docked compounds obtained from this study could aid in screening and designing new anticancer agents or selective inhibitors for chemotherapy against Bax.
Similar content being viewed by others
References
Adams JM, Cory S (2001) Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26:61–66
Andersen DO, Weber ND, Wood SG, Hughes BG, Murray BK, North JA (1991) In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives. Antivir Res 16:185–196
Arosio B, Gagliano N, Fusaro LM, Parmeggiani L, Tagliabue J, Galetti P, De Castri D, Moscheni C, Annoni G (2000) Aloe-emodin quinone pretreatment reduces acute liver injury induced by carbon tetrachloride@@. Pharmacol Toxicol 87:229–233
Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA (2001) Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A 9:10037–10041
Berendsen HJC, Postma JPM, van Gunsteren WF, Dinola A, Haak JR (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684–3690
Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, Feng Z, Gilliland GL, Iype L, Jain S, Fagan P, Marvin J, Padilla D, Ravichandran V, Schneider B, Thanki N, Weissig H, Westbrook JD, Zardecki C (2002) The Protein Data Bank. Acta Crystallogr D: Biol Crystallogr 58:899–907
Bren M, Florian J, Mavri J, Bren U (2007) Do all pieces make a whole? Thiele cumulants and the free energy decomposition. Theor Chem Acc 117:535–540
Bren U, Martinek V, Florian J (2006) Decomposition of the solvation free energies of deoxyribonucleoside triphosphates using the free energy perturbation method. J Phys Chem B 110:12782–12788
Budihardjo I, Oliver H, Lutter M, Luo X, Wang X (1999) Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15:269–290
Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318–1321
Darden T, York D, Pedersen L (1993) Particle mesh Ewald: an N log(N) method for Ewald sums in large systems. J Chem Phys 98:10089–10092
DeLano WL (2010) The PyMOL Molecular Graphics System, Internet, http://www.pymol.org. Accessed 2 Dec 2010
Engelmann I, Bauer G (2000) How can tumor cells escape intercellular induction of apoptosis? Anticancer Res 20:2297–2306
Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z (1985) Medicinal plants in therapy. Bull World Health Organ 63:965–981
Gasteiger J, Marsili M (1980) Iterative partial equalization of orbital electro negativity—a rapid access to atomic charges. Tetrahedron 36:3219–3228
Hartwell JL (1982) Plants used against cancer: a survey. Quarterman, Lawrence, pp 438–439
Hess B, Bekker H, Berendsen HJC, Fraaije JGEM (1997) LINCS: A linear constraint solver for molecular simulations. J Comput Chem 18:1463–1472
Hess B, Kutzer C, van der Spoel D, Lindahl E (2008) GROMACS 4: algorithms for highly efficient, load-balanced and scalable molecular simulation. J Chem Theory Comput 4:435–447
Hockney RW, Goel SP, Eastwood J (1974) Quit high resolution computer models of plasma. J Comput Phys 14:148–158
HyperChem, release 7.5 for Windows, Molecular Modeling System; Hypercube, Inc and Autodesk, Inc [http://www.hyper.com/]. Accessed 8 Sep 2003
Kollman PA, Massova I, Reyes C, Kuhn B, Huo S, Chong L, Lee M, Lee T, Duan Y, Wang W, Donini O, Cieplak P, Srinivasan J, Case DA, Cheatham TC (2000) III. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res 33:889–897
Krumbiegel G, Schulz HU (1993) Rhein and aloe-emodin kinetics from senna laxatives in man. Pharmacology 47:120–124
Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8:477–486
Lee HZ (2001) Protein kinase C involvement in aloe-emodin- and emodin-induced apoptosis in lung carcinoma cell. Br J Pharmacol 134:1093–1103
Lee HZ, Hsu SL, Liu MC, Wu CH (2001) Effects and mechanisms of aloe-emodin on cell death in human lung squamous cell carcinoma. Eur J Pharmacol 431:287–295
Lin ML, LuYC SHL, Lin HT, Lee CC, Kang SE, Lai TC, Chung JG, Chen SS (2011) Destabilization of CARP mRNAs by aloe-emodin contributes to caspase-8-mediated p53-independent apoptosis of human carcinoma cells. J Cell Biochem 112:1176–1191
Lin JG, Chen GW, Li TM, Chouh ST, Tan TW, Chung JG (2006) Aloe-emodin induces apoptosis in T24 human bladder cancer cells through the p53 dependent apoptotic pathway. J Urol 175:343–347
Lin SY, Yang JH, Hsia TC, Lee JH, Chiu TH, Wei YH, Chung JG (2005) Effect of inhibition of aloe-emodin on N-acetyltransferase activity and gene expression in human malignant melanoma cells. Melanoma Res 15:489–494
Lin SY, Lai WW, Ho CC, Yu FS, Chen GW, Yang JS, Liu KC, Lin ML, Wu PP, Fan MJ, Chung JG (2009) Emodin induces apoptosis of human tongue squamous cancer SCC-4 cells through reactive oxygen species and mitochondria-dependent pathways. Anticancer Res 29:327–335
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3–25
Lipinski CA, Lombardo F, Dominy W, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Del Rev 46:3–26
Mahajan NP, Linder K, Berry G, Gordon GW, Heim R, Herman B (1998) Bcl-2 and Bax interactions in mitochondria probed with green fluorescent protein and fluorescence resonance energy transfer. Nat Biotechnol 16:547–552
Masaldan S, Iyer VV (2012) Exploration of effects of emodin in selected cancer cell lines: enhanced growth inhibition by ascorbic acid and regulation of LRP1 and AR under hypoxia-like conditions. J Appl Toxicol. doi:10.1002/jat.2823
Mijatovic S, Maksimovic-Ivanic D, Radovic J, Dj M, Lj H, Vuckvic O, Stosic-Grujicic S, Mostarica Stojkovic M, Trajkovic V (2005) Anti-glioma action of aloe emodin: the role of ERK inhibition. Cell Mol Life Sci 62:589–598
Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (2007) AutoDock, Version 4.0.1. The Scripps Research Institute, La Jolla
Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS, Nettesheim D, Chang BS, Thompson CB, Wong SL, Shi-chung NG, Fesik SW (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381:335–341
Muto A, Hori M, Sasaki Y, Saitoh A, Yasuda I, Maekawa T, Uchida T, Asakura K, Nakazato T, Kaneda T, Kizaki M, Ikeda Y, Yoshida T (2007) Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitor. Mol Cancer Ther 6:987–994
Nuessler V, Stotzer O, Gullis E, Pelka-fleischer R, Pogrebnaik A, Gieseler F, Wilmanns W (1999) Bcl-2, Bax and Bcl-xL expression in human sensitive and resistant leukemia cell lines. Leukemia 13:1864–1872
O’Connor L, Huang DC, O’Reilly LA, Strasser A (2000) Apoptosis and cell division. Curr Opin Cell Biol 12:257–263
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics 2002. CA Cancer J Clin 55:74–108
Parrinello M, Rahman A (1981) Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys 52:7182–7190
Pecere T, Gazzola MV, Mucignat C, Parolin C, Vecchia FD, Cavaggioni A, Basso G, Diaspro A, Salvato B, Carli M, Palu G (2000) Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res 60:2800–2804
Pecere T, Sarinella F, Salata C, Gatto B, Bet A, Dalla Vecchia F, Diaspro A, Carli M, Palumbo M, Palu G (2003) Involvement of p53 in specific anti-neuroectodermal tumor activity of aloe-emodin. Int J Cancer 106:836–847
Sanner MF, Huey R, Dallakyan S, Karnati S, Lindstrom W, Morris GM, Norledge B, Omelchenko A, Stoffler D, Vareille G (2007) AutoDockTools, version 1.4.5. The Scripps Research Institute, La Jolla
Sawada N, Nakashima S, Banna Y, Yamakawa H, Hayashi K, Takenaka K, Nishimura Y, Sakai N, Nozawa Y (2000) Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells. Cell Death Differ 7:761–772
Shanno DF (1970) Conditioning of quasi-Newton methods for function minimization. Math Comput 24:647–656
Sharp KA, Honig B (1990) Electrostatic interactions in macromolecules: theory and applications. Annu Rev Biophys Biophys Chem 19:301–332
Shrake A, Rupley JA (1973) Environment and exposure to solvent of protein atoms. Lysozyme and insulin. J Mol Biol 79:351–371
Sitkoff D, Sharp KA, Honig B (1994) Accurate calculation of hydration free energies using macroscopic solvent models. J Phys Chem 97:1978–1988
Srinvas G, Babykutty S, Sathiadevan PP, Srinivas P (2007) Molecular mechanism of emodin action: transition from laxative ingredient to an antitumor agent. Med Res Rev 27:591–608
Surh YJ (2003) Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3:768–780
Suzuki M, Youle RJ, Tjandra N (2000) Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 103:645–654
Tan Y, Demeter MR, Ruan H, Comb MJ (2000) BAD Ser-15 phosphorylation regulates BAD Bcl-XL interaction and cell survival. J Biol Chem 275:25865–25869
Acknowledgments
Authors wishes to thank the Department of Biotechnology-Bioinformatics Facility, Government of India for providing facilities for the work (F.No. BT/BI/25/2001/2006). The authors gratefully acknowledge their gratitude to the University Grant Commission (UGC), New Delhi for the financial support. Chaitanya wishes to thank the CSIR, New Delhi for the Senior Research Fellowship. The coauthor B. Babajan (no. F.4-2/2006 (BSR)/13-843/2013 (BSR)) thank UGC Dr. D.S. Kothari Post Doctoral Program for providing financial assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mulakayala, C., Banaganapalli, B., Mulakayala, N. et al. Design and evaluation of new chemotherapeutics of aloe-emodin (AE) against the deadly cancer disease: an in silico study. J Chem Biol 6, 141–153 (2013). https://doi.org/10.1007/s12154-013-0097-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12154-013-0097-2